Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Aug;18(8):1290-7.
doi: 10.3201/eid1808.111202.

Factors related to increasing prevalence of resistance to ciprofloxacin and other antimicrobial drugs in Neisseria gonorrhoeae, United States

Affiliations

Factors related to increasing prevalence of resistance to ciprofloxacin and other antimicrobial drugs in Neisseria gonorrhoeae, United States

Edward Goldstein et al. Emerg Infect Dis. 2012 Aug.

Abstract

Using data from the Gonococcal Isolate Surveillance Project, we studied changes in ciprofloxacin resistance in Neisseria gonorrhoeae isolates in the United States during 2002-2007. Compared with prevalence in heterosexual men, prevalence of ciprofloxacin-resistant N. gonorrhoeae infections showed a more pronounced increase in men who have sex with men (MSM), particularly through an increase in prevalence of strains also resistant to tetracycline and penicillin. Moreover, that multidrug resistance profile among MSM was negatively associated with recent travel. Across the surveillance project sites, first appearance of ciprofloxacin resistance in heterosexual men was positively correlated with such resistance for MSM. The increase in prevalence of ciprofloxacin resistance may have been facilitated by use of fluoroquinolones for treating gonorrhea and other conditions. The prominence of multidrug resistance suggests that using other classes of antimicrobial drugs for purposes other than treating gonorrhea helped increase the prevalence of ciprofloxacin-resistant strains that are also resistant to those drugs.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Semiannual prevalence of resistance to ciprofloxacin in Neissseria gonorrhoeae isolates from the Gonococcal Isolate Surveillance Program for men who have sex with men (MSM), heterosexual men, and bisexual men.
Figure 2
Figure 2
Semiannual prevalence of the ciprofloxacin (Cipro)–resistant type of Neisseria gonorrhoeae for men who have sex with men (A) and heterosexual men (B), stratified by resistance characteristics to tetracycline (tet) and penicillin (pen).
Figure 3
Figure 3
Semiannual prevalence of recent travel history in different type carriers for men who have sex with men (A) and heterosexual men (B). Ciprofloxacin (Cipro) sensitive, MIC <0.0625 μm/L.
Figure 4
Figure 4
First month of appearance of ciprofloxacin resistance in Neisseria gonorrhoeae isolates from heterosexual men and from men who have sex with men (MSM). ALB, Albuquerque, NM; ATL, Atlanta, GA; BAL, Baltimore, MD; BHM, Birmingham, AL; CHI, Chicago, IL; CLE, Cleveland, OH; LBC, Long Beach, CA; MIA, Miami, FL; MIN, Minneapolis, MN; PHI, Philadelphia, PA; PHX, Phoenix, AZ; POR, Portland, OR.

Similar articles

Cited by

References

    1. Centers for Disease Control and Prevention. Gonococcal Isolate Surveillance Project annual report. 2007. [cited 2012 May 22]. http://www.cdc.gov/std/gisp2007/GISPSurvSupp2007Complete.pdf
    1. Fox KK, Whittington WL, Levine WC, Moran JS, Zaidi AA, Nakashima AK. Gonorrhea in the United States, 1981–1996. Demographic and geographic trends. Sex Transm Dis. 1998;25:386–93. 10.1097/00007435-199808000-00011 - DOI - PubMed
    1. Barry PM, Klausner JD. The use of cephalosporins for gonorrhea: the impending problem of resistance. Expert Opin Pharmacother. 2009;10:555–77. 10.1517/14656560902731993 - DOI - PMC - PubMed
    1. Workowski KA, Berman SM, Douglas JM Jr. Emerging antimicrobial resistance in Neisseria gonorrhoeae: urgent need to strengthen prevention strategies. Ann Intern Med. 2008;148:606–13. - PubMed
    1. Centers for Disease Control and Prevention. 1993 sexually transmitted diseases treatment guidelines. MMWR Recomm Rep. 1993;42(RR-14):1–102. - PubMed

Publication types

MeSH terms

LinkOut - more resources